|
|
|
 |
 Congress at a Glance |
|
Scientific Programme
|
|
Satellite Programme
|
|
Maps of the Venue
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
| 09:00-11:05
|
|
S.17:
 Treatment track
Advances in understanding the role of stress in substance abuse: recent clinical findings |
|
| Chairs: |
Theodora Duka, United Kingdom |
| |
Wim van den Brink, The Netherlands |
|
|
|
|
| 09:50 |
|
|
|
| 09:00-11:05
|
|
S.18:
 Clinical research track
Recent advances in our understanding of unipolar depression and psychosis in adolescents |
|
| Chairs: |
Celso Arango, Spain |
| |
Bernadka Dubicka, United Kingdom |
|
|
|
|
| 10:40 |
|
|
S.18.05
Genetics of childhood onset of mood disorders
|
|
|
James L. Kennedy, Canada
|
|
|
|
| 09:00-11:05
|
|
S.19:
 Interface track
TEM symposium - Translational issues in dementia |
|
| Chairs: |
Agneta Nordberg, Sweden |
| |
Hilkka Soininen, Finland |
|
|
|
|
| 09:25 |
|
|
S.19.02
The role of glycogen synthase kinase 3 (GSK3) in the onset of Alzheimer´s disease. Use of GSK3 inhibitor for the treatment of the disease
|
|
|
Jesús Avila, Spain
|
|
|
|
| 09:50 |
|
|
S.19.03
Network dysfunction perspective on Alzheimer's disease and pharmacological implications
|
|
|
Lennart Mucke, USA
|
|
|
|
| 10:40 |
|
|
S.19.05
Neuropsychology: does it predict clinical outcome?
|
|
|
Ove Almkvist, Sweden
|
| Lecture cancelled, there will be a GENERAL DISCUSSION
|
|
|
| 09:00-11:05
|
|
S.20:
 Preclinical track
The mechanism of action of mood stabilisers: studies in animal models |
|
| Chairs: |
Robert H. Belmaker, Israel |
| |
Arne Mørk, Denmark |
|
|
|
|
|
|
|
Treatment
track
Clinical
research track
Interface
track
Preclinical
track
Educational updates
track